| Product Code: ETC8846595 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The neurodegenerative disease market in the Philippines is expanding due to the rising prevalence of conditions such as Alzheimers, Parkinsons, and Huntingtons disease. With an aging population, the demand for effective treatment options, caregiving services, and rehabilitation programs is increasing. Government health initiatives and research funding are also supporting market development.
The growing aging population and increasing cases of Alzheimers, Parkinsons, and other neurodegenerative disorders are key drivers of this market in the Philippines. Advances in diagnostic imaging, biomarker research, and drug development contribute to improved treatment options. Additionally, increased government support for elderly care and neurological research enhances market expansion.
The neurodegenerative disease market struggles with early diagnosis and treatment affordability. Many Filipinos with conditions such as Alzheimer`s and Parkinson`s disease face delays in receiving a proper diagnosis due to limited neurological expertise. Additionally, the high cost of neurodegenerative disease treatments makes them inaccessible to a significant portion of the population.
The increasing burden of neurodegenerative diseases such as Alzheimers and Parkinsons in the Philippines has created strong investment opportunities in research, treatment, and caregiving services. Investors can explore pharmaceuticals, regenerative medicine, and AI-driven diagnostics. With growing healthcare funding and demand for elderly care solutions, companies in this sector have high growth potential.
The government has implemented policies to address neurodegenerative diseases such as Alzheimers and Parkinsons disease. These include funding for public health programs that provide diagnostic and treatment services. The government also supports caregiver training programs and research into new therapies for neurodegenerative conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Neurodegenerative Disease Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Neurodegenerative Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Neurodegenerative Disease Market - Industry Life Cycle |
3.4 Philippines Neurodegenerative Disease Market - Porter's Five Forces |
3.5 Philippines Neurodegenerative Disease Market Revenues & Volume Share, By Indication Type, 2021 & 2031F |
3.6 Philippines Neurodegenerative Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 Philippines Neurodegenerative Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in the Philippines |
4.2.2 Growing awareness and healthcare infrastructure for early diagnosis and treatment |
4.2.3 Rising geriatric population leading to higher incidence of neurodegenerative diseases |
4.3 Market Restraints |
4.3.1 Limited access to advanced treatment options and healthcare facilities in remote areas |
4.3.2 High costs associated with neurodegenerative disease medications and therapies |
4.3.3 Lack of skilled healthcare professionals specializing in neurodegenerative diseases |
5 Philippines Neurodegenerative Disease Market Trends |
6 Philippines Neurodegenerative Disease Market, By Types |
6.1 Philippines Neurodegenerative Disease Market, By Indication Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Neurodegenerative Disease Market Revenues & Volume, By Indication Type, 2021- 2031F |
6.1.3 Philippines Neurodegenerative Disease Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.1.4 Philippines Neurodegenerative Disease Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.1.5 Philippines Neurodegenerative Disease Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.6 Philippines Neurodegenerative Disease Market Revenues & Volume, By Huntington Disease, 2021- 2031F |
6.1.7 Philippines Neurodegenerative Disease Market Revenues & Volume, By Other Indication Types, 2021- 2031F |
6.2 Philippines Neurodegenerative Disease Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Neurodegenerative Disease Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 Philippines Neurodegenerative Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.4 Philippines Neurodegenerative Disease Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F |
6.2.5 Philippines Neurodegenerative Disease Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F |
6.2.6 Philippines Neurodegenerative Disease Market Revenues & Volume, By Other Drug Types, 2021- 2031F |
7 Philippines Neurodegenerative Disease Market Import-Export Trade Statistics |
7.1 Philippines Neurodegenerative Disease Market Export to Major Countries |
7.2 Philippines Neurodegenerative Disease Market Imports from Major Countries |
8 Philippines Neurodegenerative Disease Market Key Performance Indicators |
8.1 Number of specialized neurology centers and clinics established in the Philippines |
8.2 Percentage increase in government funding allocated for neurodegenerative disease research and treatment |
8.3 Average wait time for patients to receive a diagnosis and start treatment |
9 Philippines Neurodegenerative Disease Market - Opportunity Assessment |
9.1 Philippines Neurodegenerative Disease Market Opportunity Assessment, By Indication Type, 2021 & 2031F |
9.2 Philippines Neurodegenerative Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 Philippines Neurodegenerative Disease Market - Competitive Landscape |
10.1 Philippines Neurodegenerative Disease Market Revenue Share, By Companies, 2024 |
10.2 Philippines Neurodegenerative Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here